Meta-Narrative

Investigation into PED Endorsement Controversy

4 articles First seen: June 12, 2026

AI Analysis

The articles collectively highlight a brewing controversy surrounding Dr. Neal ElAttrache, the medical director for the Los Angeles Dodgers, who is under investigation by Major League Baseball (MLB) for allegedly endorsing the use of performance-enhancing drugs (PEDs) in the recovery of UFC fighter Conor McGregor. This scrutiny follows a report in the New York Times that suggested ElAttrache had supported McGregor's therapeutic use of these substances, raising questions about the ethical implications of such endorsements in professional sports. The inquiry reflects broader concerns regarding the use of PEDs across sports and the accountability of medical professionals in these situations. As the investigation unfolds, the narrative underscores the intersection of sports medicine, ethics, and regulatory oversight in professional athletics. The implications of this case could resonate beyond MLB, potentially affecting perceptions of medical practices within sports and the ongoing battle against doping in competitive environments.

Related Articles

New York Post Jun 12, 12:56 AM

MLB to Interview Dodgers Doctor Regarding Support for McGregor's PED Use

MLB is set to question Dr. Neal ElAttrache, who oversees medical services for the Dodgers and Rams, after a report suggested he endorsed the use of performance-enhancing drugs for Conor McGregor's recovery. The inquiry comes in light of a New York Times article detailing these claims.

New York Post Jun 12, 06:40 PM

MLB to Investigate Dodgers Physician Dr. Neal ElAttrache

MLB will conduct an investigation into Dr. Neal ElAttrache, the head physician for the Dodgers, after a report suggested he backed a performance-enhancing drug exemption for Conor McGregor. The investigation is a response to the claims made in the New York Times.